# Loss to follow-up during tuberculosis treatment and 5-year mortality in Brazil: A target trial emulation

Source: [PLOS Medicine](https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1005303) · 2026-11-18 · Medicine
Page: https://themorning.science/story/loss-to-follow-up-during-tuberculosis-treatment-and-5-year-mortality-in-brazil-a-f301d8ae079018eb
Kind: research · Impact: medium

## In brief

- A target trial emulation study in Brazil examined loss to follow-up during tuberculosis treatment and 5-year mortality.
- The study was published in PLOS Medicine on 2026-11-18 by researchers including Evelyn Lepka de Lima and Jason R. Andrews.
- The headline links loss to follow-up during TB treatment to mortality, based on the study's 5-year outcomes.

## Why it matters

Patients who drop out of tuberculosis treatment may face higher risk of death, so tracking and retaining patients in care matters for TB control programmes. The study's target trial emulation design uses observational data to estimate effects that would otherwise need a randomised trial.

## Timeline

- 2026-11-18: Study published in PLOS Medicine

## Coverage

- [Loss to follow-up during tuberculosis treatment and 5-year mortality in Brazil: A target trial emulation](https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1005303) — PLOS Medicine, 2026-11-18

Tags: tuberculosis, loss to follow-up, mortality, brazil, epidemiology

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
